GlassScriptPhysician profile
William John Nicholas
NPI 1356387484
$22,098.46
in general payments reported to CMS, 2019-2025
22 companies · $2,260 in 2025
The $2,260 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $341 · 2021: $545 · 2022: $892 · 2023: $1,760 · 2024: $5,056 · 2025: $2,260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,700 · Food and Beverage: $3,292 · Education: $83.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,699.80 |
| Food and Beverage | $3,292.31 |
| Education | $83.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $10,858.59 | 2019-2022 | |
| Medtronic, INC. | $4,209.14 | 2021-2025 | Azure Xt Dr Mri Surescan, Micra, Linq II |
| Abbott Laboratories | $1,751.45 | 2019-2025 | Esprit, Ensite |
| Edwards Lifesciences Corporation | $1,678.26 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Angiodynamics, INC. | $1,542.31 | 2024 | Alphavac |
| Stryker Corporation | $676.27 | 2025 | Clottriever Bold Catheter, Flowtriever |
| W. L. Gore & Associates, INC. | $366.17 | 2023-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Boston Scientific Corporation | $194.90 | 2024-2025 | Ekosonic, Watchman Flx |
| Shockwave Medical, INC | $190.03 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $89.49 | 2019 | |
| Cathworks, INC. | $89.05 | 2024 | Ffrangio |
| E.R. Squibb & Sons, L.L.C. | $83.78 | 2024-2025 | Camzyos |
| Chiesi USA, INC. | $83.64 | 2024 | Kengreal |
| Novartis Pharmaceuticals Corporation | $76.90 | 2023-2025 | |
| Pfizer INC. | $40.91 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $40.67 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $26.74 | 2019-2022 | |
| Livanova USA, INC. | $24.91 | 2023 | Lifesparc |
| Cardiovascular Systems INC. | $20.98 | 2022-2023 | Diamondback Coronary |
| Cagent Vascular INC | $18.62 | 2024 | Serrantor |
| Philips North America LLC | $17.95 | 2025 | Azurion 7 M20 |
| Bard Peripheral Vascular, INC. | $17.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Nicholas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.